Glaucarubin

(1β,2α,11β,12α,15β)-1,2,11,12-Tetrahydroxy-16-oxo-11,20-epoxypicras-3-en-15-yl (2S)-2-hydroxy-2-methylbutanoate

(1β,2α,11β,12α,15β)-1,2,11,12-Tetrahydroxy-16-oxo-11,20-epoxypicras-3-en-15-yl-(2S)-2-hydroxy-2-methylbutanoat

(2S)-2-Hydroxy-2-méthylbutanoate de (1β,2α,11β,12α,15β)-1,2,11,12-tétrahydroxy-16-oxo-11,20-époxypicras-3-én-15-yle

Butanoic acid, 2-hydroxy-2-methyl-, (1β,2α,11β,12α,15β)-11,20-epoxy-1,2,11,12-tetrahydroxy-16-oxopicras-3-en-15-yl ester, (2S)-

EH6H7VS52J

Glaucarubin

Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,2,3,3aβ,4,6aβ,7,7aα,10,11,11a,11bα-dodecahydro-1α,2α,4β,10α,11β-pentahydroxy-3α,8,11aβ-trimethyl-5H-1,11cβ-(epoxymethano)phenanthro[10,1-bc]pyran-5-one

Picras-3-en-16-one, 11,20-epoxy-1,2,11,12-tetrahydroxy-15-(2-hydroxy-2-methyl-1-oxobutoxy)-, [1β,2α,11β,12α,15β(S)]-

T C66665/BQ 3AAB S AX KOV RO FUTJ C1 DQ EQ G1 MOVXQ2&1 O1 PQ QQ